EuroPharMedTech (EPMT) helps biopharma teams turn data, science, and regulation into real‑world impact. We combine market access strategy, medical and regulatory expertise, and AI‑driven solutions to accelerate decisions, strengthen evidence, and support compliant growth.



Our team brings hands‑on experience across Health Technology Assessment (HTA), pharmacovigilance, medical affairs, medical writing, real‑world evidence and data computing, and IT & AI enablement for SMEs. We also build SaaS tools including our CLEVAIR‑HTA platform. This platform streamline evidence reviews, automate research workflows, and keep teams aligned with evolving EU requirements.



Headquartered in Brussels and working across Europe and the U.S., we partner with pharmaceutical SMEs and innovators to deliver practical, compliant solutions that improve time‑to‑insight, reduce operational burden, and keep the focus on patient value.



What we deliver: market access and HTA support; medical, regulatory, and technical writing; pharmacovigilance; medical affairs and medical information & publicity; data computing & RWE; IT & AI support for SMEs; EU AI Act readiness; and training & eLearning for your teams.